DE10346751A1 - Clot lysis assay - Google Patents
Clot lysis assay Download PDFInfo
- Publication number
- DE10346751A1 DE10346751A1 DE2003146751 DE10346751A DE10346751A1 DE 10346751 A1 DE10346751 A1 DE 10346751A1 DE 2003146751 DE2003146751 DE 2003146751 DE 10346751 A DE10346751 A DE 10346751A DE 10346751 A1 DE10346751 A1 DE 10346751A1
- Authority
- DE
- Germany
- Prior art keywords
- clot lysis
- lysis assay
- streptokinase
- psac
- reteplase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Die vorliegende Erfindung bezieht sich auf eine neue Methode eines Clot-Lyse-Assays, der zur Untersuchung der Thrombolyse, insbesondere durch Urokinase (u-PA), t-PA, Streptokinase (SK), Plasminogen-Streptokinase-Aktivator-Komplex (PSAC), Reteplase (RP) oder Tenecteplase (TP), verwendet werden kann.The present invention relates to a novel method of a clot lysis assay useful in the study of thrombolysis, in particular by urokinase (u-PA), t-PA, streptokinase (SK), plasminogen streptokinase activator complex (PSAC). , Reteplase (RP) or Tenecteplase (TP) can be used.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2003146751 DE10346751A1 (en) | 2003-10-06 | 2003-10-06 | Clot lysis assay |
PCT/DE2004/002224 WO2005033711A2 (en) | 2003-10-06 | 2004-10-05 | Clot lysis assay |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2003146751 DE10346751A1 (en) | 2003-10-06 | 2003-10-06 | Clot lysis assay |
Publications (1)
Publication Number | Publication Date |
---|---|
DE10346751A1 true DE10346751A1 (en) | 2005-04-21 |
Family
ID=34353347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2003146751 Withdrawn DE10346751A1 (en) | 2003-10-06 | 2003-10-06 | Clot lysis assay |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE10346751A1 (en) |
WO (1) | WO2005033711A2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3838529A1 (en) * | 1988-11-14 | 1990-05-17 | Behringwerke Ag | GLOBALTEST FOR DETECTING THE MAIN COMPONENTS OF THE FIBRINOLYSIS SYSTEM |
DE3917949A1 (en) * | 1989-05-30 | 1991-01-24 | Schering Ag | New fibrin specific thrombolytic agent v-PA |
DE19756773A1 (en) * | 1997-12-19 | 1999-06-24 | Dade Behring Marburg Gmbh | New procedure and diagnostic tool for hemostasis diagnostics |
DE19903693A1 (en) * | 1998-04-24 | 1999-10-28 | Centeon Pharma Gmbh | Protease for activation of coagulation factor VII |
US20030017147A1 (en) * | 1996-09-20 | 2003-01-23 | Guy L Reed | Composition and method for enhancing fibrinolysis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5110727A (en) * | 1987-04-03 | 1992-05-05 | Cardiovascular Diagnostics, Inc. | Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles |
-
2003
- 2003-10-06 DE DE2003146751 patent/DE10346751A1/en not_active Withdrawn
-
2004
- 2004-10-05 WO PCT/DE2004/002224 patent/WO2005033711A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3838529A1 (en) * | 1988-11-14 | 1990-05-17 | Behringwerke Ag | GLOBALTEST FOR DETECTING THE MAIN COMPONENTS OF THE FIBRINOLYSIS SYSTEM |
DE3917949A1 (en) * | 1989-05-30 | 1991-01-24 | Schering Ag | New fibrin specific thrombolytic agent v-PA |
US20030017147A1 (en) * | 1996-09-20 | 2003-01-23 | Guy L Reed | Composition and method for enhancing fibrinolysis |
DE19756773A1 (en) * | 1997-12-19 | 1999-06-24 | Dade Behring Marburg Gmbh | New procedure and diagnostic tool for hemostasis diagnostics |
DE19903693A1 (en) * | 1998-04-24 | 1999-10-28 | Centeon Pharma Gmbh | Protease for activation of coagulation factor VII |
Non-Patent Citations (4)
Title |
---|
BENNET,W.F.:High resolution analysis of functional determinants on human tissue-type plasminogen activator. In:J.Biol.Chem.,(1991),266 (8),S.5191-201 * |
Datenband PubMed bei NCBI, Adresse www.ncbi.nlm.nih. gov Zusammenfassung zu: RHODES N.P. & WILLIAMS D.F.: Plasma recalcification as a measure of contact phase activation and heparinization efficacy after contact with biomaterials.In:Biomaterials (1994),15,(1),S.35-7 (recherchiert am 30.06.2004) * |
Datenband PubMed bei NCBI,Adresse www.ncbi.nlm.nih.gov Zusammenf. zu SAKHAROV,D.V.,u.a.:Fibrin-specificity of a * |
REED,G.L.,u.a.:Synergistic fibrinolysis:combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin..In:Proc.Natl.Acad. Sci,USA (1990),87,(3),S.1114-8 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005033711A2 (en) | 2005-04-14 |
WO2005033711A3 (en) | 2005-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017023444A2 (en) | pressure hardened steel part, pressure hardened laser welded steel part, steel part manufacturing process and part use | |
ATE416789T1 (en) | COMBINATIONS FOR HCV TREATMENT | |
DE502006009314D1 (en) | PROCESS FOR PRODUCING A HANDLE | |
IL217489A (en) | Modified urinary plasminogen activator (u-p a) polypeptides with altered substrate specificity or activity and compositions and uses thereof | |
CU23586A1 (en) | METHODS AND PROTEINS FOR THE PROPHLACTIC AND / OR THERAPEUTIC TREATMENT OF THE FOUR SEROTYPES OF THE DENGUE VIRUS AND OTHER FLAVIVIRUS | |
DE50214734D1 (en) | OLIGO OR POLYALKYLENE GLYCOL-COUPLED THROMBININHIBITORS | |
CL2011000206A1 (en) | Biocidal composition comprising ciprodinil and fluazinam; method to control diseases, in useful plants or in propagation material, caused by phytopathogens (div. sol. n ° 2602-06). | |
Yang et al. | A bi-functional anti-thrombosis protein containing both direct-acting fibrin (ogen) olytic and plasminogen-activating activities | |
WO2010039538A3 (en) | Flavivirus inhibitors and methods for their use | |
ATE454673T1 (en) | WATERMARKING A COMPUTER PROGRAM CODE USING EQUIVALENT MATHEMATICAL EXPRESSIONS | |
MX2022014161A (en) | Sars-cov-2 vaccines. | |
DE10346751A1 (en) | Clot lysis assay | |
NO20034278L (en) | Compositions and Methods for Treating HCV Infections | |
AR053324A1 (en) | ADDITIVES WITH SILICATE CONTENTS FOR WELL TREATMENTS AND RELATED METHODS | |
AR053433A1 (en) | METHODS TO PREPARE AND USE GELIFYING AGENTS OF SULFONATED OR CARBOXYLATED POLYSACARIDS | |
EA200301271A1 (en) | METHOD OF DIAGNOSTIC OR PREDICTION OF MAIN RESPIRATORY BACTERIAL PATHOGENES IN THE SUBJECT | |
GB0620255D0 (en) | Antibody and uses thereof | |
DE60217357D1 (en) | METHOD FOR DETERMINING THE EFFECTS OF BOTULINUM TOXINES | |
HUP0301804A2 (en) | Antithrombotic agents | |
AU2021246398A8 (en) | Fusion protein suitable for dissolving fibrin clot, and pharmaceutical composition containing said fusion protein | |
Shende et al. | Modeling and analysis of hammer of Impact testing machine: a review | |
Fan et al. | Research on ultrasonic shot peening through numerical simulation | |
CN107435410A (en) | Compound brick block | |
何燕霖 et al. | Computer aided design of free-machinability prehardened mold steel for plastic | |
Chun-hua et al. | Statistical analysis of dynamic parameters of silty clay in Beijing area [J] |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OM8 | Search report available as to paragraph 43 lit. 1 sentence 1 patent law | ||
8127 | New person/name/address of the applicant |
Owner name: PHILIPPS-UNIVERSITAET MARBURG, 35037 MARBURG, DE |
|
8110 | Request for examination paragraph 44 | ||
R016 | Response to examination communication | ||
R016 | Response to examination communication | ||
R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee |